Profil
Pekka Ilmari Simula was the founder of Targovax Oy, serving as Director from 2014 to 2015, founded in 2009.
Current jobs include Chief Executive Officer & Director at Meles Consulting Oy, Chairman at Suomen Bioteollisuus ry since 2018, Director at MediSapiens Oy since 2020, Director at Neurotar Oy since 2021, Director at Sartar Therapeutics Oy since 2018, Partner at Innovestor Oy, and Partner at Innovestor Ventures Oy since 2022.
Former jobs include Chief Executive Officer at Hermo Pharma Oy from 2013 to 2014, Chief Executive Officer at Laurantis Pharma Oy, Chief Executive Officer at Herantis Pharma Oyj from 2013 to 2020, Project Director at CRF Box Oy, Director at Opia Games Oy, Independent Director at Bioretec Ltd., Manager-Global Program at Varian Medical Systems, Inc. from 2004 to 2009, and Project Manager at Accenture Plc.
Education includes a graduate degree from Aalto University.
Postes actifs de Pekka Ilmari Simula
| Sociétés | Poste | Début |
|---|---|---|
Suomen Bioteollisuus ry | Président | 01/01/2018 |
Meles Consulting Oy
Meles Consulting Oy Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Directeur Général | - |
Neurotar Oy
Neurotar Oy Medical DistributorsDistribution Services Supplies laboratory tools | Directeur/Membre du Conseil | 01/05/2021 |
MediSapiens Oy
MediSapiens Oy Packaged SoftwareTechnology Services Provides solutions for bioinformatics analysis | Directeur/Membre du Conseil | 01/05/2020 |
Sartar Therapeutics Oy | Directeur/Membre du Conseil | 01/09/2018 |
Innovestor Oy
Innovestor Oy Investment ManagersFinance Functions as an alternative investment manager | Analyste en capital-investissement | - |
Innovestor Ventures Oy
Innovestor Ventures Oy Investment ManagersFinance Innovestor Ventures Oy invests in companies located in the Nordic and Baltics countries. The firm targets companies with operations in the fields cleantech, consumer technology, enterprise software, health technology, industrial technologies and life science. It provides financing for seed and early stage capital requirements. It makes minority investments ranging from EUR 0.5 to EUR 2 million and also co-investments. | Private Equity Investor | 01/02/2022 |
Anciens postes connus de Pekka Ilmari Simula
| Sociétés | Poste | Fin |
|---|---|---|
| HERANTIS PHARMA OYJ | Directeur Général | 01/07/2020 |
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Focuses on the development and commercialization of targeted cancer immunotherapy | Directeur Général | 09/11/2012 |
| ░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Pekka Ilmari Simula
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Varian Medical Systems, Inc.
Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and supplies radiotherapy medical devices for treating cancer & develops related software solutions | Health Technology |
Accenture Plc
Accenture Plc Information Technology ServicesTechnology Services Operates as an investment holding company with interest in providing management consulting, technology and outsourcing services | Technology Services |
CRF Box Oy
CRF Box Oy Packaged SoftwareTechnology Services Provides electronic patient reported outcome assessment solutions for the life sciences industry | Technology Services |
Bioretec Ltd.
Bioretec Ltd. Medical SpecialtiesHealth Technology Markets, develops, and manufactures bioabsorbable, bioactive, and drug-releasing surgical implants for orthopedic for surgery | Health Technology |
Aalto University
Aalto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Suomen Bioteollisuus ry | |
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Focuses on the development and commercialization of targeted cancer immunotherapy | Health Technology |
MediSapiens Oy
MediSapiens Oy Packaged SoftwareTechnology Services Provides solutions for bioinformatics analysis | Technology Services |
Hermo Pharma Oy
Hermo Pharma Oy Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Herantis Pharma Oyj
Herantis Pharma Oyj Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products to treat neurological disorders | Health Technology |
Opia Games Oy | |
Innovestor Oy
Innovestor Oy Investment ManagersFinance Functions as an alternative investment manager | Finance |
Innovestor Ventures Oy
Innovestor Ventures Oy Investment ManagersFinance Innovestor Ventures Oy invests in companies located in the Nordic and Baltics countries. The firm targets companies with operations in the fields cleantech, consumer technology, enterprise software, health technology, industrial technologies and life science. It provides financing for seed and early stage capital requirements. It makes minority investments ranging from EUR 0.5 to EUR 2 million and also co-investments. | Finance |
Neurotar Oy
Neurotar Oy Medical DistributorsDistribution Services Supplies laboratory tools | Distribution Services |
Meles Consulting Oy
Meles Consulting Oy Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Sartar Therapeutics Oy |
















